Active Stocks in Review: Menlo Therapeutics Inc. (NASDAQ:MNLO), Atento S.A. (NYSE:ATTO)

0

Menlo Therapeutics Inc. (NASDAQ:MNLO)

Menlo Therapeutics Inc. (NASDAQ:MNLO) represented a move of 0 percent or $0.34 per share and closed its previous day trading session at $5.66. 0 Shares were traded in the last trading session with an Average Volume of 182.26 Million Shares. The stock currently has a Market Capitalization of 131.76 Million.

Menlo Therapeutics Inc. is a late stage biopharmaceutical company. It focused on the development of serlopitant and treatment of chronic itch and chronic refractory cough. The company’s product pipeline consists of Prurigo Nodularis Itch, Atopic Dermatitis Itch, Psoriasis Itch and Refractory Chronic Cough which are in clinical stage. Menlo Therapeutics Inc. is headquartered in Redwood City, California.

The stock traded between $ 5.40 and $39.86 over 1-Year time period showing its price to sales ratio of 9.83. Menlo Therapeutics Inc. (NASDAQ:MNLO) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-19.08 and 200-Day Simple Moving Average of $-53.74. Its Price to Free Cash Flow is 0 and Price to Book of 0.89.

Analyst’s recommended the stock as 2.2 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Menlo Therapeutics Inc. (NASDAQ:MNLO) reported its Actual EPS of $-0.56/share. The analysts offering Earnings Estimates for the company were believing that Menlo Therapeutics Inc. could bring EPS of $-0.89/share. The difference between Actual EPS and Estimated EPS was 0.33 Percent. Thus showing an Earnings Surprise of 37.1 Percent.

Atento S.A. (NYSE:ATTO)

In the last trading session, Atento S.A. (NYSE:ATTO) added its value by 0% closing at the price of $4.62. The stock currently has market capitalization of 343.5 Million, with average volume of 128.73 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Atento S.A. (NYSE:ATTO) is showing beta of 0.42. This particular value of beta suggests that Atento S.A. (NYSE:ATTO) has historically moved 42% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Atento S.A. (NYSE:ATTO) is at $-0.08.

The stock currently has RSI of 20.35. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Atento S.A. is a provider of customer relationship management and business process outsourcing (CRM BPO) services in Latin America and Spain. Its CRM BPO services include customer service, sales, credit management, technical support, back office, and service desk, as well as other BPO process services, such as training activities, workstation infrastructure, interactive voice response port implementation, telecommunications infrastructure, application development, and others. The Company’s clients are mostly multinational corporations in sectors such as telecommunications, banking and finance, health, consumption and public administration, among others. Atento S.A. is based in Luxembourg.

Atento S.A. (NYSE:ATTO) topped its 52-week high price of $10.45 on 01/18/18 and 52-Week Low Price of $ 4.53 on 12/04/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 4.48% and monthly volatility of 5.28% respectively.